Landscape Of Protein Post-Translational Modifications In Age-Related Neurodegenerative Disorders: Implications In Protein Aggregation, Altered Cellular Processes, And Therapeutics

Aging Pathway
Therapeutic
The paper reveals that chemical modifications to proteins, known as post-translational modifications, are crucial in the development of age-related neurodegenerative disorders by influencing protein aggregation and cellular processes, offering new therapeutic possibilities.
Author

Gemini

Published

March 15, 2026

Our bodies rely on proteins to perform countless functions, but sometimes these vital molecules can go awry, especially as we age. In conditions like Alzheimer’s and Parkinson’s, a major problem is the buildup of faulty or clumped proteins in brain cells. Recent research sheds light on how tiny chemical tags, called post-translational modifications (PTMs), are key players in this process. PTMs are like switches that can change a protein’s behavior after it’s been made. Normally, these modifications help our cells’ internal “recycling” systems, known as autophagy and proteasome systems, clear out damaged proteins and keep everything running smoothly. However, as we get older, these chemical tags can become imbalanced, leading to proteins being incorrectly modified. This can cause proteins to misfold, clump together, and end up in the wrong places, ultimately contributing to the progression of these debilitating brain disorders. The exciting news is that by understanding these specific chemical changes, scientists are exploring new ways to develop treatments. By targeting the enzymes that add or remove these tags with special small molecules, it might be possible to restore healthy protein function and potentially slow down or even prevent the damage seen in these age-related conditions.


Source: link to paper